Abbott Laboratories Posts Solid Q3 Earnings, Trims Full-Year Forecast

Abbott Laboratories (ABT - Get Report) posted third quarter earnings that were largely in-line with analysts' forecasts, but trimmed the upper end of its full-year profit outlook as international sales were hit by a stronger U.S. dollar.